Mechanical circulatory support (MCS) and heart transplantation are established therapies for advanced heart failure and cardiogenic shock. Technological advances have improved outcomes, including randomized evidence supporting the use of temporary MCS, such as percutaneous ventricular assist devices, in selected patien...
Laith Alhuneafat, Omar Obeidat, Kevin G. Buda et al.· Frontiers in Cardiovascular...· 0 citations
BACKGROUND
Direct oral anticoagulants (DOACs) are preferred over VKA for stroke prevention in atrial fibrillation/flutter (AF), but concerns exist regarding their use in antiphospholipid syndrome (APS). The safety and effectiveness of DOACs in AF patients with isolated lupus anticoagulant (LA) who do not meet APS crite...
Omar Obeidat, Laith Alhuneafat, Mohamed F. Ismail et al.· American Journal of the Medi...· 0 citations
Among CTO patients with LVEF with LVEF, VA and mortality were frequent, particularly with OMT, supporting prospective studies to confirm benefit and refine patient selection for revascularization strategies.
Ahmad Jabri, Laith Alhuneafat, Omar Obeidat et al.· Future Cardiology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.